Disclosures for "Effects of Vitamin D Supplementation on Disease Activity after a Clinically Isolated Syndrome According to Plasma Vitamin D Levels: Ancillary Analysis of the D-lay MS Randomized Controlled Trial"
-
The institution of Dr. Rival has received research support from France SEP. The institution of Dr. Rival has received research support from Novartis.
-
Dr. DEMATTEI has nothing to disclose.
-
Dr. Boulet has nothing to disclose.
-
Prof. MURA-TODESCO has nothing to disclose.
-
Dr. Agherbi has nothing to disclose.
-
Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.